Sulindac targets nuclear ß-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.

MLA

Boon, E. M. J., et al. “Sulindac Targets Nuclear SS-Catenin Accumulation and Wnt Signalling in Adenomas of Patients with Familial Adenomatous Polyposis and in Human Colorectal Cancer Cell Lines.” British Journal of Cancer, vol. 90, no. 1, Jan. 2004, pp. 224–29. EBSCOhost, https://doi.org/10.1038/sj.bjc.6601505.

APA

Boon, E. M. J., Keller, J. J., Wormhoudt, T. A. M., Giardiello, F. M., Offerhaus, G. J. A., van der Neut, R., & Pals, S. T. (2004). Sulindac targets nuclear ß-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. British Journal of Cancer, 90(1), 224–229. https://doi.org/10.1038/sj.bjc.6601505

Chicago

Boon, E.M.J., J.J. Keller, T.A.M. Wormhoudt, F.M. Giardiello, G.J.A. Offerhaus, R. van der Neut, and S.T. Pals. 2004. “Sulindac Targets Nuclear SS-Catenin Accumulation and Wnt Signalling in Adenomas of Patients with Familial Adenomatous Polyposis and in Human Colorectal Cancer Cell Lines.” British Journal of Cancer 90 (1): 224–29. doi:10.1038/sj.bjc.6601505.